Sequence-dependent synergistic effect of aumolertinib-pemetrexed combined therapy on EGFR-mutant non-small-cell lung carcinoma with pre-clinical and clinical evidence

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 3,137 followers.

RT @JournalofExper1: Published! ✅ Sequence-dependent synergistic effect of #aumolertinib-pemetrexed combined therapy on #EGFR-mutant non-s…

Sequence-dependent synergistic effect of #aumolertinib-pemetrexed combined therapy on #EGFR-mutant non-small-cell #lungcarcinoma with pre-clinical and clinical evidence

Published! ✅ Sequence-dependent synergistic effect of #aumolertinib-pemetrexed combined therapy on #EGFR-mutant non-small-cell #lungcarcinoma with pre-clinical and clinical evidence Read here ⏬ https://t.co/sCKxw3n7oP @IREISGufficiale https://t.co/TjyKK

New article: Sequence-dependent synergistic effect of aumolertinib-pemetrexed combined therapy on EGFR-mutant non-small-cell lung carcinoma with pre-clinical and clinical evidence https://t.co/O1faRHf0kX #lungcancer #oncology https://t.co/JXFrYqHZ4g

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.